DE-SPAC (Details) - EUR (€) € in Thousands |
12 Months Ended | |
|---|---|---|
Apr. 30, 2024 |
Dec. 31, 2024 |
|
| Disclosure of detailed information about business combination [line items] | ||
| Share listing expenses | € 71,630 | |
| SCHMID Group N.V | Pegasus | ||
| Disclosure of detailed information about business combination [line items] | ||
| Number of shares issued | 7,843,501 | |
| Number of warrants issued | 17,000,000 | 21,000,000 |
| Fair value of identifiable net assets | € 3,500 | € 3,529 |
| Cash | 47,700 | |
| Current liabilities assumed | 10,600 | 9,300 |
| Warrant liabilities assumed | 1,400 | 5,300 |
| Deferred underwriting commissions assumed | 2,300 | |
| Share listing expenses | 71,600 | € 71,630 |
| Incremental transaction costs directly attributable to the issuance of new shares | € 4,600 |
| X | ||||||||||
- Definition The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount recognised as of the acquisition date for current liabilities assumed in a business combination. [Refer: Current liabilities; Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount recognized as of the acquisition date for deferred underwriting commissions assumed in a business combination. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued in pursuant to reverse recapitalization. No definition available.
|
| X | ||||||||||
- Definition The number of warrants issued in pursuant to reverse recapitalization. No definition available.
|
| X | ||||||||||
- Definition The amount of expenses relating to difference between the fair value of the net assets contributed and the fair value of equity instruments provided to former shareholders is treated as an listing expense. No definition available.
|
| X | ||||||||||
- Definition The amount of incremental transaction costs directly attributable to the issuance of new shares. No definition available.
|
| X | ||||||||||
- Definition The amount recognized as of the acquisition date for warrant liabilities assumed in a business combination. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|